Zenlabs Ethica (530697)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At 38 rupees, this is a tiny 25 crore market cap company. Graham would tell me to look at the numbers coldly. Book value is 16.14 rupees, so I am paying 2.36 times the net assets. But what are those assets earning? The return on equity is a negative 18 percent, and the latest quarter showed a net loss of 2 crore on sales of 12 crore. That is no margin of safety. The P/E of 59 is meaningless when profits are falling by 22 percent and sales are shrinking by 2.28 percent. The Piotroski score of 3 out of 9 reinforces a weak balance sheet. There is a glimmer: ROCE is 5.69 percent, so operating capital isn't totally dead, and annualized sales of roughly 48 crore against a 25 crore market cap gives a price-to-sales below 0.7. But that only helps if management can turn those sales into profits. The stock has doubled from its 52-week low of 16.50; the market is anticipating a recovery that hasn't shown up in earnings. As an investor, I don't bet on hope. I need evidence. Without promoter holding data or debt details, I can't trust the stewardship. This is a possible turnaround, but only for a speculator, not a value investor. I would wait on the sidelines until profitability returns and the Piotroski score improves.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer